Cholinergic Receptor, Nicotinic, alpha 5 (Neuronal) (CHRNA5) Peptide
Quick Overview for Cholinergic Receptor, Nicotinic, alpha 5 (Neuronal) (CHRNA5) Peptide (ABIN8096955)
Target
Source
Application
-
-
Purpose
- CHRNA5 Peptide
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-CHRNA5 antibody ( ARP34967_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- CHRNA5 (Cholinergic Receptor, Nicotinic, alpha 5 (Neuronal) (CHRNA5))
-
Background
-
Targeted Subunit: alpha-5
Background Information: Nicotinic acetylcholine receptors (nAChRs), such as CHRNA5, are members of a superfamily of ligand-gated ion channels that mediate fast signal transmission at synapses. The nAChRs are thought to be (hetero)pentamers composed of homologous subunits.
Alternative Symbols: LNCR2
-
Molecular Weight
- 53kDa
-
Gene ID
- 1138
-
NCBI Accession
- NP_000736
-
UniProt
- P30532
Target
-